Parkway Life Real Estate Investment (C2PU) AI Stock Analysis

• Market Cap: $2.63B
• Dividend Yield: 3.76%
• Average Volume (3M): 932.25K
• Price to Earnings (P/E): 30.6
• Beta (1Y): 0.33
• Revenue Growth: 2.55%
• EPS Growth: -23.99%
• Country: SG
• Employees: 23
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): N/A
• Shares Outstanding: 652,453,060
• 10 Day Avg. Volume: 754,280
• 30 Day Avg. Volume: 932,253
• PEG Ratio: -4.11
• Price to Book (P/B): 1.46
• Price to Sales (P/S): 15.87
• P/FCF Ratio: 49.23
• Enterprise Value/Market Cap: 1.35
• Enterprise Value/Revenue: 23.51
• Enterprise Value/Gross Profit: 25.13
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $5.15
• Price Target Upside: 28.77% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 60 Neutral
• Price Target: S$4.50 ▲(12.50% Upside)

The overall stock score of 60 reflects strong profitability and efficient cost management, but challenges in revenue growth and a high P/E ratio weigh on the valuation. Technical indicators suggest stability with a slight bullish sentiment, but the lack of earnings call data and notable corporate events limits further insights.

Positive Factors

Strong Profit Margins

The company's strong profit margins indicate efficient cost management and a robust business model, essential for long-term profitability.

Board Strengthening

Strengthening the board enhances governance and strategic direction, supporting sustainable growth and resilience in the healthcare REIT sector.

Stable Balance Sheet

A stable balance sheet with moderate leverage ensures financial flexibility and supports long-term operational stability.

Negative Factors

Revenue Decline

A decline in revenue suggests potential challenges in market demand or competitive pressures, impacting future growth prospects.

Free Cash Flow Concerns

Inability to calculate free cash flow growth indicates potential issues in cash generation, which could affect reinvestment and debt servicing.

Unit Issuance for Fees

Issuing new units for management fees can dilute existing unitholder value and alter the trust's market positioning, affecting long-term returns.

Parkway Life Real Estate Investment Business Overview & Revenue Model

Company Description

Parkway Life Real Estate Investment (C2PU) is a leading real estate investment trust (REIT) based in Singapore, primarily focusing on the healthcare and senior living sectors. The company invests in a diversified portfolio of income-generating properties, including nursing homes, hospitals, and other healthcare facilities across Asia. Parkway Life REIT aims to deliver sustainable returns to its unitholders by capitalizing on the growing demand for healthcare services driven by an aging population and increasing healthcare expenditure.

How the Company Makes Money

Parkway Life Real Estate Investment generates revenue primarily through rental income from its portfolio of healthcare properties. The company leases its properties to operators of healthcare facilities, who pay rent on a long-term basis, ensuring a steady cash flow. Additionally, Parkway Life REIT benefits from the appreciation of property values over time, which can lead to capital gains upon the sale of assets. The company may also explore strategic partnerships with healthcare operators and developers, further enhancing its revenue opportunities. Furthermore, Parkway Life REIT may receive management fees and other income from its investment services, contributing to its overall earnings.

Parkway Life Real Estate Investment Financial Statement Overview

Summary

Parkway Life Real Estate Investment demonstrates strong profitability with a high gross profit margin of 87.5% and a net profit margin of 65.6%. However, revenue has declined by 14.1%, indicating challenges in revenue generation. The balance sheet is stable with moderate leverage, and cash flow generation is healthy but could improve in terms of free cash flow growth.

Income Statement

The income statement shows a strong gross profit margin of 87.5% and a solid net profit margin of 65.6% for 2024. However, the revenue has declined by 14.1% compared to the previous year, indicating potential challenges in revenue generation. The EBIT and EBITDA margins are robust at 78.6%, reflecting efficient cost management.

Balance Sheet

The balance sheet is stable with a moderate debt-to-equity ratio of 0.56, indicating a balanced approach to leveraging. The return on equity is relatively low at 6.05%, suggesting room for improvement in generating returns for shareholders. The equity ratio stands at 61.5%, showcasing a strong equity base.

Cash Flow

Cash flow analysis reveals a strong operating cash flow to net income ratio of 1.63, indicating healthy cash generation relative to net income. However, the free cash flow growth is not calculable due to a previous negative value, and the free cash flow to net income ratio is moderate at 48.7%.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	151.16M	144.85M	147.47M	129.97M	120.70M	120.89M
Gross Profit	141.43M	126.74M	124.59M	107.52M	98.43M	99.49M
EBITDA	0.00	113.88M	121.20M	112.14M	100.01M	95.24M
Net Income	83.67M	95.04M	100.47M	41.14M	331.88M	87.22M
Balance Sheet
Total Assets	2.62B	2.55B	2.33B	2.34B	2.35B	2.07B
Cash, Cash Equivalents and Short-Term Investments	49.04M	29.47M	28.50M	40.01M	25.79M	22.66M
Total Debt	927.48M	886.11M	828.47M	851.89M	828.01M	793.65M
Total Liabilities	1.03B	981.20M	919.58M	931.66M	910.43M	883.36M
Stockholders Equity	1.59B	1.57B	1.41B	1.41B	1.43B	1.18B
Cash Flow
Free Cash Flow	0.00	46.68M	77.65M	30.74M	78.17M	85.73M
Operating Cash Flow	0.00	95.79M	108.69M	94.63M	89.86M	90.31M
Investing Cash Flow	0.00	-239.93M	-49.56M	-125.18M	-74.99M	-28.57M
Financing Cash Flow	0.00	147.35M	-67.92M	47.75M	-9.98M	-61.46M

Parkway Life Real Estate Investment Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 4.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C2PU, the sentiment is Negative. The current price of 4 is below the 20-day moving average (MA) of 4.09, below the 50-day MA of 4.14, and below the 200-day MA of 4.03, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 29.39 is Positive, neither overbought nor oversold. The STOCH value of 4.95 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C2PU.

Parkway Life Real Estate Investment Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TQ5	71 Outperform	$4.08B	15.52	2.37%	4.29%	-18.13%	40.87%
T82U	67 Neutral	$3.95B	-203.03	-0.32%	4.75%	0.01%	-110.22%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
C2PU	60 Neutral	$2.63B	30.58	5.49%	3.76%	2.55%	-23.99%
9A4U	56 Neutral	S$2.21B	-19.34	-4.88%	6.81%	10.51%	-40.93%
TS0U	56 Neutral	S$1.90B	-24.82	-2.15%	6.12%	-11.65%	-137.98%

Parkway Life Real Estate Investment Corporate Events

Parkway Life REIT to Announce Q3 2025 Business Update

Parkway Life REIT will release its third-quarter business update for the financial period ending 30 September 2025 on 5 November 2025, before trading hours. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic positioning in the real estate investment market.

Parkway Life REIT Strengthens Board with New Appointments

Parkway Life Real Estate Investment Trust has announced a significant renewal of its Board of Directors, aimed at strengthening its governance and strategic direction. The appointment of Mr. Robin Hu Yee Cheng as Chairman and Mrs. Eng-Kwok Seat Moey as an Independent Director, along with the continued service of Ms. Theresa Goh Cheng Keow, highlights the company’s commitment to robust governance and sustainable growth. These changes are expected to enhance PLife REIT’s resilience and long-term value creation for its unitholders, reinforcing its reputation in the healthcare real estate investment sector.

Parkway Life REIT Issues New Units for Management Fee Payment

Parkway Trust Management Limited, the manager of Parkway Life Real Estate Investment Trust, has announced the issuance of 32,665 new units to itself as part payment for management fees for the second quarter of 2025. This issuance, priced at approximately S$4.11 per unit, increases the total units in circulation to 652,453,073, potentially impacting the trust’s market positioning and stakeholder interests by altering unit distribution and management fee structures.

Parkway Life REIT Secures New Facility Agreement for Financial Stability

Parkway Life REIT has entered into a new facility agreement to refinance its existing bank borrowings and support various financial needs, including working capital and business acquisitions. This agreement includes specific conditions that could trigger prepayment obligations, potentially affecting facilities worth approximately S$918 million, highlighting the company’s strategic financial management approach to maintain operational stability.

Parkway Life REIT Completes Divestment of Malaysian Property

Parkway Life Real Estate Investment Trust has completed the divestment of its strata units and lots at MOB Specialist Clinics in Kuala Lumpur, Malaysia, to Pantai Medical Centre Sdn. Bhd. This strategic move is part of Parkway Life REIT’s ongoing efforts to optimize its portfolio and enhance value for its stakeholders.